stock.name

Mirati Therapeutics Inc

MRTX

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mirati Therapeutics IncMirati Therapeutics Inc00%-77%--
$66.66

Current Fair Value

13.6% upside

Undervalued by 13.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-976,434,000.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-12.15
Beta0.0
Outstanding Shares70,147,706
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales-
Price to Book Ratio4.52
Enterprise Value to Revenue-25.57
Enterprise Value to EBIT1.28
Enterprise Value to Net Income1
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Mirati Therapeutics Inc

CEO: Charles Baum